RESUMO
PURPOSE: Amanita phalloides poisoning with high mortality is rare but serious. The aim of this study is to identify the risk indicators of death in patients with Amanita phalloides poisoning and a good score tool to predict prognosis. METHODS: In this respective study (1/2009-12/2018), the patients (n = 105) with Amanita phalloides poisoning from two hospitals of China Medical University who met the inclusion/exclusion criteria were included. The laboratory markers and the clinical scoring systems including Child-Turcotte-Pugh (CTP), Sequential organ failure assessment (SOFA), Liver injury and Failure evaluation (LiFe), Chronic liver failure-organ failure score system (CLIF-OF), King's College criteria (KCH criteria), Model for end-stage liver disease (MELD) and Platelet-bilirubin-albumin (PALBI) within 24 h of admission to the two hospitals were analyzed and area under the curve (AUC) analyses were also performed regarding the prediction of death. RESULTS: The data analysis indicated that high international normalized ratio (INR) (>3.6, AUC = 0.941) and plasma ammonia (>95.1 µmol/L, AUC = 0.805) were closely associated with mortality after multivariate logistic regression. CLIF-OF (>9) within 24 h with really good diagnostic accuracy (>90%) significantly outperformed the other scores in predicting mortality. CONCLUSION: CLIF-OF (>9) within 24 h of admission is considered as a satisfactory and practical tool to predict a poor outcome of Amanita phalloides poisoning.
Assuntos
Amanita , Doença Hepática Terminal/fisiopatologia , Intoxicação Alimentar por Cogumelos/mortalidade , Escores de Disfunção Orgânica , Amônia/sangue , Área Sob a Curva , China , Doença Hepática Terminal/etiologia , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Valor Preditivo dos Testes , Prognóstico , Estudos Retrospectivos , Medição de Risco , Fatores de RiscoRESUMO
OBJECTIVE: This study was designed to determine the fatality rate of suspected cyclopeptide-containing mushroom ingestions reported to the National Poison Data System (NPDS). BACKGROUND: Although silibinin reportedly improves survival in suspected cyclopeptide-containing mushroom ingestions, the greater than 20% untreated fatality rate that is often cited is based on decades-old data. An ongoing open-label silibinin trial will likely use historical cases as comparators. A recent single poison control center (PCC) study showed a fatality rate of 8.3%. This study was designed to validate those findings in the NPDS. METHODS: This study was an 11-year (1/1/2008-12/31/2018) retrospective review of suspected cyclopeptide-containing mushroom ingestions reported to NPDS. Inclusion and exclusion criteria were the same as the ongoing silibinin trial: Age >2-years-old; history of eating foraged mushrooms; gastrointestinal symptoms within 48 h of mushroom ingestion; and aminotransferases above the upper limit of normal within 48 h after ingestion. Each original participating PCC confirmed eligibility, diagnosis, treatment, and outcome on included cases. RESULTS: During the study period, 8,953 mushroom exposures were reported to NPDS, of which 296 met inclusion criteria. The PCC survey response rate was 60% (28/47 PCCs), and the individual case response rate was 59% (174/296). Twenty-six cases were subsequently excluded leaving 148 included cases. The overall mortality rate was 8.8% (13/148). Mortality in silibinin/silymarin-treated vs untreated cases was 9.5% (4/42), vs 8.5% (9/106), respectively. A mycologist identified mushrooms in 16.9% of cases (25/148), of which 80% (20/25) were cyclopeptide-containing. Among these confirmed cases, the mortality rate was 10% (1/10) in both silibinin/silymarin-treated and untreated cases. CONCLUSIONS: The contemporary mortality rate of patients with presumed cyclopeptide-mushroom poisoning is only 8.8%. This likely represents improved supportive care for patients with acute liver injury and should be considered the current standard for historical controls in the United States.
Assuntos
Doença Hepática Induzida por Substâncias e Drogas/mortalidade , Intoxicação Alimentar por Cogumelos/mortalidade , Peptídeos Cíclicos/intoxicação , Antídotos/uso terapêutico , Causas de Morte , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Bases de Dados Factuais , Humanos , Mortalidade , Intoxicação Alimentar por Cogumelos/diagnóstico , Intoxicação Alimentar por Cogumelos/tratamento farmacológico , Centros de Controle de Intoxicações , Prognóstico , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Silibina/uso terapêutico , Silimarina/uso terapêutico , Fatores de Tempo , Estados UnidosRESUMO
Mushroom poisonings remain a significant cause of emergency medicine. While there are well-known species, such as Amanita phalloides, causing life-threatening poisonings, there is also accumulating evidence of poisonings related to species that have been considered edible and are traditionally consumed. In particular, the Tricholoma equestre group was reported to cause myotoxicity. In addition, particular wild mushrooms that are traditionally consumed especially in Asia and Eastern Europe have been subject to suspicion due to possible mutagenicity. Hitherto, the causative agents of these effects often remain to be determined, and toxicity studies have yielded contradictory results. Due to this, there is no consensus about the safety of these species. The issue is further complicated by difficulties in species identification and other possible sources of toxicity, such as microbiological contamination during storage, leading to sometimes opposite conclusions about the edibility of a species. This review focuses on existing data about these types of mushroom poisonings, including the still sparse knowledge about the causative chemical agents. In addition, the aim is to initiate a meta-discussion about the issue and to give some suggestions about how to approach the situation from the viewpoint of the collector, the researcher, and the practicing physician.
Assuntos
Agaricales/metabolismo , Intoxicação Alimentar por Cogumelos/etiologia , Micotoxinas/intoxicação , Agaricales/classificação , Animais , Inocuidade dos Alimentos , Humanos , Intoxicação Alimentar por Cogumelos/metabolismo , Intoxicação Alimentar por Cogumelos/mortalidade , Micotoxinas/metabolismo , Medição de Risco , Especificidade da EspécieRESUMO
The consequences of mushroom poisoning range from mild, mostly gastrointestinal, disturbances to organ failure or even death. This retrospective study describes presentations related to mushroom poisoning at an emergency department in Bern (Switzerland) from January 2001 to October 2017. Gastrointestinal disturbances were reported in 86% of the 51 cases. The National Poisons Information Centre and mycologists were involved in 69% and 61% of the cases, respectively. Identification of the mushroom type/family was possible in 43% of the cases. The most common mushroom family was Boletaceae (n = 21) and the most common mushrooms Xerocomus chrysenteron (n = 7; four being part of a cluster), Clitocybe nebularis, Lepista nuda and Lactarius semisanguifluus (n = 5 each, four being part of a cluster). Poisonous mushrooms included Amanita phalloides (n = 3, all analytically confirmed), Boletus satanas (n = 3), Amanita muscaria (n = 2) and Amanita pantherina (n = 2). There were no fatalities and 80% of the patients were discharged within 24 h. Mushroom poisoning does not appear to be a common reason for emergency consultation and most presentations were of minor severity and related to edible species (e.g., due to incorrect processing). Nevertheless, poisonous mushrooms and severe complications were also recorded. Collaboration with a poison centre and/or mycologists is of great importance, especially in high risk cases.
Assuntos
Agaricales/classificação , Serviço Hospitalar de Emergência/estatística & dados numéricos , Intoxicação Alimentar por Cogumelos/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Intoxicação Alimentar por Cogumelos/mortalidade , Intoxicação Alimentar por Cogumelos/patologia , Encaminhamento e Consulta/organização & administração , Encaminhamento e Consulta/estatística & dados numéricos , Estudos Retrospectivos , Suíça/epidemiologia , UniversidadesRESUMO
Ingestion of wild and potentially toxic mushrooms is common in the United States and many other parts of the world. US poison centers have been logging cases of mushroom exposure in The National Poison Data System (NPDS) annual publications for over 30 years. This study compiles and analyzes US mushroom exposures as reported by the NPDS from 1999 to 2016. Over the last 18 years, 133 700 cases (7428/year) of mushroom exposure, mostly by ingestion, have been reported. Cases are most frequently unintentional (83%, P < 0.001); cause no or only minor harm (86%, P < 0.001); and in children <6 years old (62%, P < 0.001). Approximately 704 (39/year) exposures have resulted in major harm. Fifty-two (2.9/year) fatalities have been reported, mostly from cyclopeptide (68-89%)-producing mushrooms ingested by older adults unintentionally. The vast majority of reported ingestions resulted in no or minor harm, although some groups of mushroom toxins or irritants, such as cyclopepides, ibotenic acid, and monomethylhydrazine, have been deadly. Misidentification of edible mushroom species appears to be the most common cause and may be preventable through education.
Assuntos
Agaricales/química , Intoxicação Alimentar por Cogumelos/epidemiologia , Micotoxinas/efeitos adversos , Centros de Controle de Intoxicações/estatística & dados numéricos , Adolescente , Adulto , Criança , Pré-Escolar , Análise de Dados , Feminino , Humanos , Masculino , Intoxicação Alimentar por Cogumelos/mortalidade , Intoxicação Alimentar por Cogumelos/prevenção & controle , Micotoxinas/toxicidade , Psilocibina/efeitos adversos , Psilocibina/toxicidade , Estados Unidos/epidemiologia , Adulto JovemRESUMO
INTRODUCTION: Mushroom intoxication (MT) can lead to acute liver injury which may result in Mushroom intoxication-related liver failure (M-ALF) requiring liver transplantation (LT). In the present study, we want to share the experience of our institute regarding living-donor LT (LDLT) due to mushroom poisoning. AIM: The aim of this study is to identify the predictors of poor prognosis in patients with ALF secondary to mushroom intoxication requiring LDLT. MATERIALS AND METHODS: All patients with MT between 2008 and 2016 were evaluated. Demographics, symptoms, interval between symptoms and admission to our institute, laboratory data, model for end-stage liver disease (MELD)/pediatric end-stage liver disease (PELD) scores, clinical course, and outcomes of supportive therapy and LT were evaluated. There were two groups in the study: Group A = responsive to supportive therapy (n = 9) versus Group B = unresponsive to supportive therapy (n = 9). RESULTS: During the study, a total of 18 patients were admitted with M-ALF. Twelve (66.7%) of them were female, and the mean age was 39.9 ± 18.2 years. All of the nine patients in Group A fully recovered with supportive therapy. In Group B, one patient died during waiting period for LT and 8 patients received LDLT LDLT. Three of the eight patients who were transplanted died in the postoperative early period within postoperative 5 days. The patients in Group B had significantly higher MELD/PELD scores and encephalopathy rate than in Group A (P < 0.05). International normalized ratio (INR), bilirubin, ammonium levels, and platelet count were significantly different between groups (P < 0.05). The patients in Group B had significantly longer interval before admission to our institute (P < 0.05). CONCLUSION: The presence of encephalopathy, higher MELD/PELD, INR, bilirubin, ammonium levels, and lower platelet count was related to poor prognosis in MT. LDLT provides a good therapeutic option in patients with M-ALF. The time is a crucial factor in successful treatment of MT. Early admission to a tertiary referral center with expertise in LT results in a better prognosis and increased survival following M-ALF.
Assuntos
Falência Hepática Aguda/etiologia , Falência Hepática Aguda/cirurgia , Transplante de Fígado , Doadores Vivos , Intoxicação Alimentar por Cogumelos/cirurgia , Adolescente , Adulto , Idoso , Bilirrubina , Criança , Pré-Escolar , Feminino , Humanos , Falência Hepática Aguda/mortalidade , Falência Hepática Aguda/terapia , Transplante de Fígado/mortalidade , Masculino , Pessoa de Meia-Idade , Intoxicação Alimentar por Cogumelos/mortalidade , Contagem de Plaquetas , Complicações Pós-Operatórias/epidemiologia , Período Pós-Operatório , Prognóstico , Centros de Atenção Terciária , Fatores de Tempo , Resultado do Tratamento , Turquia/epidemiologia , Adulto JovemRESUMO
BACKGROUND: The reported mortality rate of mushroom-induced acute liver failure with conventional treatment is 1.4%-16.9%. Emergency liver transplantation may be indicated and can be the only curative treatment option. This study aimed to assess the prognostic value of criteria for emergency liver transplantation in predicting 28-day mortality in patients with mushroom-induced acute liver injury. METHODS: A retrospective cohort study was performed between January 2005 and December 2015. All adult patients aged≥18 years admitted with mushroom intoxication at our emergency department were evaluated. All patients with acute liver injury, defined as elevation of serum liver enzymes (>5 times the upper limit of normal, ULN) or moderate coagulopathy (INR > 2.0) were included. The ability of the King's College, Ganzert's, and Escudié's criteria to predict 28-day mortality was evaluated. RESULTS: Of the 23 patients with acute liver injury following mushroom intoxication, 10 (43.5%) developed acute liver failure and subsequently died. The mean time interval from ingestion to death was 11.3⯱â¯6.6 days. Eight patients fulfilled Ganzert's criteria, while 10 patients fulfilled the King's College and Escudié's criteria for emergency liver transplantation. King's College and Escudié's criteria had 100% accuracy in predicting 28-day mortality; however, Escudié's criteria were able to identify fatal cases earlier. CONCLUSIONS: Escudié's criteria demonstrated the best performance with 100% accuracy and the ability to promptly identify fatal cases of mushroom-induced acute liver failure.
Assuntos
Doença Hepática Induzida por Substâncias e Drogas/cirurgia , Técnicas de Apoio para a Decisão , Falência Hepática Aguda/cirurgia , Transplante de Fígado , Intoxicação Alimentar por Cogumelos/complicações , Idoso , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Doença Hepática Induzida por Substâncias e Drogas/mortalidade , Tomada de Decisão Clínica , Emergências , Feminino , Humanos , Falência Hepática Aguda/induzido quimicamente , Falência Hepática Aguda/diagnóstico , Falência Hepática Aguda/mortalidade , Transplante de Fígado/efeitos adversos , Transplante de Fígado/mortalidade , Masculino , Pessoa de Meia-Idade , Intoxicação Alimentar por Cogumelos/diagnóstico , Intoxicação Alimentar por Cogumelos/mortalidade , Valor Preditivo dos Testes , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Fatores de Tempo , Resultado do TratamentoRESUMO
OBJECTIVES: The aim of this study has been to assess the characteristics of acute poisoning deaths in Poland over a period of time 2009-2013. MATERIAL AND METHODS: The analysis was based on the data obtained from the patient records stored in toxicology departments in 6 cities - Lódz, Kraków, Sosnowiec, Gdansk, Wroclaw and Poznan. Toxicological analyses were routinely performed in blood and/or urine. Major toxic substances were classified to one of the following categories: pharmaceuticals, alcohol group poisonings (ethanol and other alcohols), gases, solvents, drugs of abuse, pesticides, metals, mushrooms, others. Cases were analyzed according to the following criteria: year, age and gender of analyzed patients, toxic substance category and type of poisoning. The recorded fatal poisonings were classified according to the International Classification of Diseases. RESULTS: The record of 261 deaths were retrospectively reviewed. There were 187 males (71.64%) and 74 females (28.36%) and the male to female ratio was 2.52. Alcohol group poisonings were more frequently responsible for deaths in men compared to all poisonings, 91.1% vs. 71.6%, respectively (p < 0.05), and pharmaceutical agents were more frequently responsible for deaths in women, 47.4% vs. 28.4%, (p < 0.05). Methanol was the most common agent in the alcohol group poisonings, accounting for 43.75% (N = 49), followed by ethylene glycol, 39.29% (N = 44), and ethanol, 16.96% (N = 19). CONCLUSIONS: Epidemiological profile data from investigation of poisoning deaths in Poland may be very useful for the development of preventive programs. Int J Occup Med Environ Health 2017;30(6):897-908.
Assuntos
Intoxicação/epidemiologia , Intoxicação/mortalidade , Adulto , Álcoois/intoxicação , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/mortalidade , Feminino , Intoxicação por Gás/epidemiologia , Intoxicação por Gás/mortalidade , Humanos , Drogas Ilícitas/intoxicação , Masculino , Metais/intoxicação , Pessoa de Meia-Idade , Intoxicação Alimentar por Cogumelos/epidemiologia , Intoxicação Alimentar por Cogumelos/mortalidade , Praguicidas/intoxicação , Polônia/epidemiologia , Estudos Retrospectivos , Solventes/intoxicaçãoRESUMO
BACKGROUND & AIMS: Acute liver failure after ingestion of toxic mushrooms is a significant medical problem. Most exposures to toxic mushrooms produce no symptoms or only mild gastroenteritis, but some lead to severe hepatic necrosis and fulminant hepatic failure requiring liver transplantation. We aimed to assess mortality from mushroom poisoning and identify variables associated with survival and liver transplantation. METHODS: We collected information from 27 patients (13 male; median age, 47 years) admitted to the emergency department within 24 hours of ingesting wild mushrooms. They developed severe liver injury (serum levels of transaminases greater than 400 IU/L) and were treated with activated charcoal and N-acetylcysteine at a tertiary medical center in San Francisco, California from January 1997 through December 2014. Viral hepatitis, autoimmune liver disease, acetaminophen, salicylate toxicity, and chronic liver diseases were ruled out for all patients. We analyzed patient demographics, time since ingestion, presenting symptoms, laboratory values, and therapies administered. A good outcome was defined as survival without need for liver transplant. A poor outcome was defined as death or liver transplant. Positive predictive values were calculated, and the χ2 test was used to analyze dichotomous variables. RESULTS: Liver injury was attributed to ingestion of Amanita phalloides in 24 patients and Amanita ocreata in 3 patients. Twenty-four of the patients ingested mushrooms with meals and 3 patients for hallucinogenic purpose. At 24-48 hours after ingestion, all patients had serum levels of alanine aminotransferase ranging from 554 to 4546 IU/L (median, 2185 IU/L). Acute renal impairment developed in 5 patients. Twenty-three patients survived without liver transplantation, and 4 patients had poor outcomes (1 woman underwent liver transplantation on day 20 after mushroom ingestion, and 3 women died of hepatic failure). Of the 23 patients with peak levels of total bilirubin of 2 mg/dL or more during hospitalization, only 4 had a poor outcome. Peak serum level of aspartate aminotransferase less than 4000 IU/L, peak international normalized ratio less than 2, and a value of serum factor V greater than 30% identified patients with good outcomes with 100% positive predictive value; if these peak values were used as a cutoff, 10 of 27 patients (37%), 7 of 27 patients (26%), and 6 of 12 patients (50%), respectively, could have avoided transfer to a transplant center. CONCLUSIONS: In an analysis of 27 patients with hepatocellular damage due to mushroom (Amanita) poisoning and peak levels of total bilirubin greater than 2 mg/dL, the probability of liver transplantation or death is 17%, fulfilling Hy's law. Patients with peak levels of aspartate aminotransferase less than 4000 IU/L can be monitored in a local hospital, whereas patients with higher levels should be transferred to liver transplant centers. Women and older patients were more likely to have a poor outcome than men and younger patients.
Assuntos
Hepatite/complicações , Hepatite/patologia , Falência Hepática/mortalidade , Intoxicação Alimentar por Cogumelos/mortalidade , Intoxicação Alimentar por Cogumelos/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Hepatite/etiologia , Hepatite/cirurgia , Humanos , Falência Hepática/etiologia , Transplante de Fígado , Masculino , Pessoa de Meia-Idade , Intoxicação Alimentar por Cogumelos/complicações , Estudos Retrospectivos , São Francisco , Análise de Sobrevida , Resultado do Tratamento , Adulto JovemRESUMO
Mushroom exposures are increasing worldwide. The incidence and fatality of mushroom poisoning are reported to be increasing. Several new syndromes in mushroom poisoning have been described. Rhabdomyolytic mushroom poisoning is one of new syndromes. Russula subnigricans mushroom can cause delayed-onset rhabdomyolysis with acute kidney injury in the severely poisoned patient. There are few reports on the toxicity of R. subnigricans. This report represents the first record of R. subnigricans poisoning with rhabdomyolysis in Korea, describing a 51-year-old man who suffered from rhabdomyolysis, acute kidney injury, severe hypocalcemia, respiratory failure, ventricular tachycardia, cardiogenic shock, and death. Mushroom poisoning should be considered in the evaluation of rhabdomyolysis of unknown cause. Furthermore, R. subnigricans should be considered in the mushroom poisoning with rhabdomyolysis.
Assuntos
Injúria Renal Aguda/etiologia , Basidiomycota/patogenicidade , Intoxicação Alimentar por Cogumelos/diagnóstico , Rabdomiólise/etiologia , Choque Cardiogênico/etiologia , Basidiomycota/isolamento & purificação , Eletrocardiografia , Ventrículos do Coração/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Intoxicação Alimentar por Cogumelos/microbiologia , Intoxicação Alimentar por Cogumelos/mortalidade , Taquicardia Ventricular/etiologiaRESUMO
The present study was undertaken with a view to improving forensic medical diagnostics of intoxication with poisonous mushrooms in the cases of patients' death in a hospital. A total of 15 protocols of forensic medical examination of the corpses of the people who had died from acute poisoning were available for the analysis. The deathly toxins were amanitin and muscarine contained in various combinations in the death cap (Amanita phalloides) and the early false morels (Gyromitra esculenta and G. gigas). The main poisoning season in the former case was May and in the latter case August and September (93.4%). The mortality rate in the case of group intoxication (such cases accounted for 40% of the total) amounted to 28.6%. 40% of the deceased subjects consumed mushrooms together with alcohol. The poisoning caused the development of either phalloidin- or gyromitrin-intoxication syndromes (after consumption of Amanita phalloides and Gyromitra esculenta respectively). It is emphasized that the forensic medical experts must substantiate the diagnosis of poisoning with mushroom toxins based on the results of the chemical-toxicological and/or forensic chemical investigations. The relevant materials taken from the victim or the corpse should be dispatched for analysis not only within the first day but also on days 2-4 after intoxication. The mycological and genetic analysis must include the detection and identification of mushroom microparticles and spores in the smears from the oral cavity, vomiting matter, wash water, gastric and intestinal contents. In addition, the macro- and microscopic morphological signs, clinical data (major syndromes, results of laboratory studies, methods of treatment) should be taken into consideration as well as the time (season) of mushroom gathering, simultaneous poisoning in a group of people, and other pertinent information.
Assuntos
Amanita/patogenicidade , Amanitinas/toxicidade , Intoxicação Alimentar por Cogumelos , Micotoxinas , Adulto , Cromatografia Líquida de Alta Pressão/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Intoxicação Alimentar por Cogumelos/diagnóstico , Intoxicação Alimentar por Cogumelos/etiologia , Intoxicação Alimentar por Cogumelos/mortalidade , Intoxicação Alimentar por Cogumelos/fisiopatologia , Micotoxinas/análise , Micotoxinas/classificação , Prognóstico , Federação Russa/epidemiologia , Análise de Sobrevida , Fatores de TempoRESUMO
Poisoning is a major problem worldwide among children. Nonetheless, the offending agent, the associated morbidity and mortality vary from place to place and show changes over a period of time. The aim of this study was to investigate the medico-legal paediatric autopsies of childhood poisonings in the Eastern Black Sea Region of Turkey. Reports of autopsies performed between 2009 and 2013 in the Morgue Department of the Council of Forensic Medicine. All medico-legal paediatric autopsies in Trabzon (n:1049) were retrospectively examined. The study comprised an investigation into 62 deaths from poisoning in children aged 0-18 years. The parameters of age, sex, toxic substance category and origin were evaluated. Poisoning accounted for 5.9% of the deaths of children aged 0-18 years. Of the 62 cases, 32 (51.6%) were male and 30 (48.4%) were female, giving a female to male ratio of 1/1.1. The primary causes of fatal poisoning in children were carbon monoxide (64.5%, n = 40), followed by drugs (16.1%, n = 10), insecticides (9.7%, n = 6), mushrooms (6.5%, n = 4), and snake venom (3.2%, n = 2). The results of this study implicated carbon monoxide poisoning as a serious risk factor for mortality in our region. Childhood poisoning may be prevented by public education and simple precautions in general.
Assuntos
Intoxicação/mortalidade , Adolescente , Distribuição por Idade , Intoxicação por Monóxido de Carbono/mortalidade , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Inseticidas/intoxicação , Masculino , Intoxicação Alimentar por Cogumelos/mortalidade , Estudos Retrospectivos , Distribuição por Sexo , Venenos de Serpentes/intoxicação , Turquia/epidemiologiaRESUMO
We report the first case, to our knowledge, of amatoxin hepatotoxicity in Iowa and explore the ethical and decisional challenges of offering an investigational treatment of a rare disease. Acute liver failure due to ingestion of amatoxin-containing mushrooms is a relatively rare entity. Once amatoxin poisoning is identified, there is no clearly effective treatment, leading to a broad range of theoretically beneficial, anecdotally successful, or investigational options. The evolution of hepatotoxicity led us to offer investigational treatment with silibinin, an extract of Mediterranean milk thistle. We explore the pitfalls in medical decision-making experienced by both the patient and the physician in the face of ambiguity. The patient did well following silibinin infusion, but we are left uncertain as to whether the patient truly responded to treatment or was simply destined to recover.
Assuntos
Injúria Renal Aguda/tratamento farmacológico , Antioxidantes/uso terapêutico , Falência Hepática Aguda/tratamento farmacológico , Intoxicação Alimentar por Cogumelos/tratamento farmacológico , Silimarina/uso terapêutico , Injúria Renal Aguda/mortalidade , Idoso , Amanita , Humanos , Falência Hepática Aguda/mortalidade , Masculino , Intoxicação Alimentar por Cogumelos/mortalidade , Silibina , Sobrevida , Resultado do TratamentoRESUMO
Poisoning from Amanita group of mushrooms comprises approximately 3% of all poisonings in our country and their being responsible for nearly the entire fatal mushroom poisonings makes them important. These mushrooms contain primarily two types of toxins, amatoxins and phallotoxins. Phallotoxins have a more limited toxicity potential and they primarily consist of phalloidin (PHN) and phallacidin (PCN). Amatoxins, on the other hand, are very toxic and they primarily consist of alpha-amanitin (AA), beta-amanitin (BA) and gamma-amanitin (GA). Toxin levels can vary among various species, even among varieties of the same species, of Amanita mushroom family. Revealing the differences between the toxin compositions of the Amanita species that grow in our region may contribute to the clinics of poisonings. Our study aims at showing in detail the toxin levels in various parts of Amanita verna mushroom. A. verna mushrooms needed for toxin analysis were collected from Kozak Plateau near Ayvalik county of Balikesir, Turkey in April 2013. The mushrooms were divided into their parts as pileus, gills, stripe and volva. Following the procedures required before the analysis, the AA, BA, GA, PHN and PCN levels were measured using the RP-HPLC method. While the lowest level of amatoxin was in the volva of the mushroom, the highest was measured in the gills. This was followed by pileus and stripe where the levels were close to each other. Similarly, the highest level of phallotoxin was measured in the gills. Gamma toxin and phalloidin were at lower amounts than the other toxins. A. verna is frequently confused with edible mushrooms with white caps due to its macroscopic similarity. If just one of them is eaten by mistake by an adult person with no mushroom experience, it can easily poison them. The amount of amatoxin is more as compared to Amanita phalloides and A. phalloides var. alba. Particularly, the AA and BA levels are approximately three times higher, whereas GA levels are lower. Similarly, the level of PCN is approximately four times higher as compared to A. phalloides and A. phalloides var. alba; by contrast, the level of PNH is about a half of theirs. In summary, it can be said that A. verna is a more toxic mushroom than A. phalloides and has a higher rate of mortality. With our study, the amatoxin and phallotoxin concentrations and distribution in A. verna mushrooms were shown in detail for the first time and it would be useful to carry out more similar studies with other members of Amanita family growing in various parts of the world.
Assuntos
Amanita/química , Amanitinas/química , Intoxicação Alimentar por Cogumelos , Amanitinas/toxicidade , Cromatografia Líquida de Alta Pressão , Humanos , Intoxicação Alimentar por Cogumelos/mortalidade , Especificidade da Espécie , TurquiaAssuntos
Amanita , Intoxicação Alimentar por Cogumelos/diagnóstico , Intoxicação Alimentar por Cogumelos/terapia , Acetilcisteína/uso terapêutico , Adulto , Amanitinas/toxicidade , Amanitinas/urina , Causas de Morte , Terapia Combinada , Cuidados Críticos , Diagnóstico Diferencial , Encefalopatia Hepática/diagnóstico , Encefalopatia Hepática/mortalidade , Encefalopatia Hepática/terapia , Humanos , Testes de Função Hepática , Transplante de Fígado , Masculino , Intoxicação Alimentar por Cogumelos/mortalidade , Prognóstico , Silibina , Silimarina/uso terapêuticoRESUMO
Se presenta una serie de tres casos de pacientes adultos con intoxicación por Amanita phalloides, ocurridos entre los años 2010 y 2011. Dos pacientes eran de sexo masculino, de 40 y 75 años de edad, y la mujer de 65 años. En todos los casos se asoció el cuadro clínico a la práctica de recolección casera de hongos para preparación de alimentos (actividad sostenida durante más de 10 años en todos los casos). La recolección se realizó en zonas de robles en un caso, y en zonas de castaños en los otros dos casos. En los tres casos la consulta se realizó entre las 16 y 36 h de la ingesta. Los tres pacientes desarrollaron diarrea, hepatopatía y falla hepática sin encefalopatía. A todos se les realizó tratamiento con carbón activado seriado, aspirado duodenal y penicilina endovenosa. El trasplante hepático fue necesario en uno de los casos. No hubo secuelas hepáticas en ninguno de los pacientes. Conclusiones: la práctica de recolección de hongos silvestres para consumo humano es un hábito riesgoso si se realiza por personas inexpertas en el reconocimiento de las especies tóxicas. Si bien la intoxicación por A. phalloides es un cuadro poco frecuente, su alta morbimortalidad hace indispensable el reconocimiento temprano y abordaje oportuno por parte de los médicos.
We present a series of three cases of Amanita phalloides poisoning in adult patients admitted during the period 2010 - 2011. Two patients were males of 40 and 75 years old, and the third was a woman of 65 years old. In all cases, the poisoning was associated with the home practice of collecting wild mushroom for cooking (activity traditionally carried out for more than 10 years in all cases). Mushroom collection was carried out in areas of oak trees for one case, and in areas of chestnuts trees in the two other cases. In all three cases the admission took place between 16 and 36 hours from intake. All three patients developed diarrhea, liver disease and liver failure without encephalopathy. All patients received treatment with activated charcoal (serial administration), duodenal aspiration and intravenous penicillin. Liver transplantation was necessary in one case. There were no hepatic sequelae in any patients. Conclusions: The practice of collecting wild mushrooms for human consumption is a risky habit if performed by people untrained in recognition of toxic species. While poisoning with A. phalloides is uncommon, its high mortality makes indispensable its early recognition and treatment by physicians.
Assuntos
Humanos , Masculino , Feminino , Adulto , Idoso , Agaricus phalloides/toxicidade , Intoxicação Alimentar por Cogumelos/diagnóstico , Agaricus phalloides/análise , Argentina/epidemiologia , Fígado/patologia , Intoxicação Alimentar por Cogumelos/tratamento farmacológico , Intoxicação Alimentar por Cogumelos/mortalidadeAssuntos
Intoxicação Alimentar por Cogumelos/diagnóstico , Intoxicação Alimentar por Cogumelos/epidemiologia , Centros de Controle de Intoxicações/estatística & dados numéricos , Notificação de Doenças/legislação & jurisprudência , Notificação de Doenças/estatística & dados numéricos , Doenças Transmitidas por Alimentos , Humanos , Japão/epidemiologia , Intoxicação Alimentar por Cogumelos/mortalidadeRESUMO
The authors described three groups of patients after acute poisonings. In the first group were 60 patients after carbon tetrachioride poisoning, the second group consisted of 81 patients after mushroom poisoning and 20 patients after ethylene glycol poisoning were in the third group. Besides two patients with rare poisonings after potassium dichromate and after paraquat poisoning were analysed. All groups of patients with the kidney damage were presented from the diagnostic, differential diagnostic, conservative, ntra- and extracorporeal elimination treatment point of view. In the group of patients suffering from acute carbon tetrachloride poisoning and with acute renal failure following therapy was used: conservative treatment, exchange blood transfusion--in 4 patients in hepatic coma, renal replacement therapy (peritoneal dialysis, haemodialysis, plasmapheresis). From the total number of 60 patients 58 survived and 2 patients died in liver coma. Survival of patients after mushroom poisoning depended on amount of oral use of mushroom (Amanita phalloides), on early admission in dialysis centre and on early beginning of renal replacement therapy within 24 hr after acute poisoning. Twenty four patients from 81 patients of this group died. Main clinical signs of ethylene glycol poisoning were various neurological symptoms (cramps, hemiparesis, coma), severe metabolic acidosis (pH = 7.06 +/- 0.14), leucocytosis (26.4 +/- 5.5x 10(9)/L) and the signs of acute toxic hepatitis and of acute renal failure. Calcium oxalic crystals in urine were present in 17 patients and leucocytosis was observed in every patient. In the first 4 patients we administered intravenously ethylalcohol as an antidotum and later in other patients we used ethylalcohol in dialysis solution. The concentration of ethylalcohol in dialysis solution was 100 mg%. Severe metabolic acidosis improved in 17 patients using bicarbonate haemodialysis and 3 patients died before the possibility to use bicarbonate haemodialysis. Eighty-four hours after acute potassium dichromate poisoning and 24 hours after exchange blood transfusion during haemodialysis a 41-year old man died in haemorhagic shock, which developed after the extensive chemical burns of mucous membrane of gastrointestinal tract caused by this poison. Our patient after paraquat poisoning was treated by repeated charcoal haemoperfusion and haemodialysis. Despite of that therapy the patient died in severe respiratory insufficiency.